MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review
Identifieur interne : 002561 ( Main/Corpus ); précédent : 002560; suivant : 002562MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review
Auteurs : M. Barns ; H. Rickards ; A E CavannaSource :
- Journal of Neurology, Neurosurgery & Psychiatry [ 0022-3050 ] ; 2011-08.
Abstract
Aims To identify the prevalence of pathological gambling (PG) in patients with Parkinson's disease (PD) from studies using comparable methodology to the best general population estimates. Additionally, to collate case-control based observations regarding the clinical characteristics of this phenomenon. Methods MEDLINE, EMBASE and PyscInfo databases were searched for prospective prevalence studies which used systematic screening methods and interview based diagnosis using recognised diagnostic criteria for PD. The same search strategy was used to identify case-control studies examining the clinical characteristics of PG. Results Five prospective studies were included in this review with a total of 1032 patients with PD. 3.2% of all patients fulfilled the diagnostic criteria for PG, compared to 0.43–1% in the general population based on North American surveys. The prevalence in men was 1% higher than in women, although this was not statistically significant. The prevalence of PG among patients on dopamine agonists was 5.7%. Younger age of PD onset, increased novelty seeking behaviours and personal/family history of alcohol misuse were all associated with PG. Psychiatric co-morbidities including other impulse control disorders were commonly reported, although no statistically significant associations have been found. Conclusions Currently available evidence-based data suggest a high prevalence of PG among patients with PD. Dopamine agonist use was strongly associated with PG across all studies. Patients who develop PG present with specific clinical characteristics which are suggestive of underlying susceptibility factors.
Url:
DOI: 10.1136/jnnp-2011-300504.13
Links to Exploration step
ISTEX:743E6B37337BCD28D68489871C683C25D343E9A2Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review</title><author><name sortKey="Barns, M" sort="Barns, M" uniqKey="Barns M" first="M" last="Barns">M. Barns</name></author><author><name sortKey="Rickards, H" sort="Rickards, H" uniqKey="Rickards H" first="H" last="Rickards">H. Rickards</name></author><author><name sortKey="Cavanna, A E" sort="Cavanna, A E" uniqKey="Cavanna A" first="A E" last="Cavanna">A E Cavanna</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:743E6B37337BCD28D68489871C683C25D343E9A2</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1136/jnnp-2011-300504.13</idno><idno type="url">https://api.istex.fr/document/743E6B37337BCD28D68489871C683C25D343E9A2/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002561</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review</title><author><name sortKey="Barns, M" sort="Barns, M" uniqKey="Barns M" first="M" last="Barns">M. Barns</name></author><author><name sortKey="Rickards, H" sort="Rickards, H" uniqKey="Rickards H" first="H" last="Rickards">H. Rickards</name></author><author><name sortKey="Cavanna, A E" sort="Cavanna, A E" uniqKey="Cavanna A" first="A E" last="Cavanna">A E Cavanna</name></author></analytic><monogr></monogr><series><title level="j">Journal of Neurology, Neurosurgery & Psychiatry</title><title level="j" type="abbrev">J Neurol Neurosurg Psychiatry</title><idno type="ISSN">0022-3050</idno><idno type="eISSN">1468-330X</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2011-08">2011-08</date><biblScope unit="volume">82</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="e2">e2</biblScope></imprint><idno type="ISSN">0022-3050</idno></series><idno type="istex">743E6B37337BCD28D68489871C683C25D343E9A2</idno><idno type="DOI">10.1136/jnnp-2011-300504.13</idno><idno type="href">jnnp-82-e2-5.pdf</idno><idno type="ArticleID">jnnp-2011-300504.13</idno><idno type="local">jnnp;82/8/e2-m</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-3050</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Aims To identify the prevalence of pathological gambling (PG) in patients with Parkinson's disease (PD) from studies using comparable methodology to the best general population estimates. Additionally, to collate case-control based observations regarding the clinical characteristics of this phenomenon. Methods MEDLINE, EMBASE and PyscInfo databases were searched for prospective prevalence studies which used systematic screening methods and interview based diagnosis using recognised diagnostic criteria for PD. The same search strategy was used to identify case-control studies examining the clinical characteristics of PG. Results Five prospective studies were included in this review with a total of 1032 patients with PD. 3.2% of all patients fulfilled the diagnostic criteria for PG, compared to 0.43–1% in the general population based on North American surveys. The prevalence in men was 1% higher than in women, although this was not statistically significant. The prevalence of PG among patients on dopamine agonists was 5.7%. Younger age of PD onset, increased novelty seeking behaviours and personal/family history of alcohol misuse were all associated with PG. Psychiatric co-morbidities including other impulse control disorders were commonly reported, although no statistically significant associations have been found. Conclusions Currently available evidence-based data suggest a high prevalence of PG among patients with PD. Dopamine agonist use was strongly associated with PG across all studies. Patients who develop PG present with specific clinical characteristics which are suggestive of underlying susceptibility factors.</div></front></TEI><istex><corpusName>bmj</corpusName><author><json:item><name>M Barns</name></json:item><json:item><name>H Rickards</name></json:item><json:item><name>A E Cavanna</name></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>British Neuropsychiatry Association 24th AGM, 10/11 February 2011, Institute of Child Health, Central London</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Aims To identify the prevalence of pathological gambling (PG) in patients with Parkinson's disease (PD) from studies using comparable methodology to the best general population estimates. Additionally, to collate case-control based observations regarding the clinical characteristics of this phenomenon. Methods MEDLINE, EMBASE and PyscInfo databases were searched for prospective prevalence studies which used systematic screening methods and interview based diagnosis using recognised diagnostic criteria for PD. The same search strategy was used to identify case-control studies examining the clinical characteristics of PG. Results Five prospective studies were included in this review with a total of 1032 patients with PD. 3.2% of all patients fulfilled the diagnostic criteria for PG, compared to 0.43–1% in the general population based on North American surveys. The prevalence in men was 1% higher than in women, although this was not statistically significant. The prevalence of PG among patients on dopamine agonists was 5.7%. Younger age of PD onset, increased novelty seeking behaviours and personal/family history of alcohol misuse were all associated with PG. Psychiatric co-morbidities including other impulse control disorders were commonly reported, although no statistically significant associations have been found. Conclusions Currently available evidence-based data suggest a high prevalence of PG among patients with PD. Dopamine agonist use was strongly associated with PG across all studies. Patients who develop PG present with specific clinical characteristics which are suggestive of underlying susceptibility factors.</abstract><qualityIndicators><score>5.089</score><pdfVersion>1.6</pdfVersion><pdfPageSize>595.276 x 793.701 pts</pdfPageSize><refBibsNative>false</refBibsNative><keywordCount>1</keywordCount><abstractCharCount>1646</abstractCharCount><pdfWordCount>853</pdfWordCount><pdfCharCount>5974</pdfCharCount><pdfPageCount>1</pdfPageCount><abstractWordCount>228</abstractWordCount></qualityIndicators><title>MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review</title><genre><json:string>abstract</json:string></genre><host><volume>82</volume><pages><first>e2</first></pages><issn><json:string>0022-3050</json:string></issn><issue>8</issue><genre></genre><language><json:string>unknown</json:string></language><eissn><json:string>1468-330X</json:string></eissn><title>Journal of Neurology, Neurosurgery & Psychiatry</title></host><publicationDate>2011</publicationDate><copyrightDate>2011</copyrightDate><doi><json:string>10.1136/jnnp-2011-300504.13</json:string></doi><id>743E6B37337BCD28D68489871C683C25D343E9A2</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/743E6B37337BCD28D68489871C683C25D343E9A2/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/743E6B37337BCD28D68489871C683C25D343E9A2/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/743E6B37337BCD28D68489871C683C25D343E9A2/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>BMJ Publishing Group Ltd</publisher><availability><p>BMJ</p></availability><date>2011</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review</title><author><persName><forename type="first">M</forename><surname>Barns</surname></persName></author><author><persName><forename type="first">H</forename><surname>Rickards</surname></persName></author><author><persName><forename type="first">A E</forename><surname>Cavanna</surname></persName></author></analytic><monogr><title level="j">Journal of Neurology, Neurosurgery & Psychiatry</title><title level="j" type="abbrev">J Neurol Neurosurg Psychiatry</title><idno type="pISSN">0022-3050</idno><idno type="eISSN">1468-330X</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2011-08"></date><biblScope unit="volume">82</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="e2">e2</biblScope></imprint></monogr><idno type="istex">743E6B37337BCD28D68489871C683C25D343E9A2</idno><idno type="DOI">10.1136/jnnp-2011-300504.13</idno><idno type="href">jnnp-82-e2-5.pdf</idno><idno type="ArticleID">jnnp-2011-300504.13</idno><idno type="local">jnnp;82/8/e2-m</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2011</date></creation><langUsage><language ident="en">en</language></langUsage><abstract><p>Aims To identify the prevalence of pathological gambling (PG) in patients with Parkinson's disease (PD) from studies using comparable methodology to the best general population estimates. Additionally, to collate case-control based observations regarding the clinical characteristics of this phenomenon. Methods MEDLINE, EMBASE and PyscInfo databases were searched for prospective prevalence studies which used systematic screening methods and interview based diagnosis using recognised diagnostic criteria for PD. The same search strategy was used to identify case-control studies examining the clinical characteristics of PG. Results Five prospective studies were included in this review with a total of 1032 patients with PD. 3.2% of all patients fulfilled the diagnostic criteria for PG, compared to 0.43–1% in the general population based on North American surveys. The prevalence in men was 1% higher than in women, although this was not statistically significant. The prevalence of PG among patients on dopamine agonists was 5.7%. Younger age of PD onset, increased novelty seeking behaviours and personal/family history of alcohol misuse were all associated with PG. Psychiatric co-morbidities including other impulse control disorders were commonly reported, although no statistically significant associations have been found. Conclusions Currently available evidence-based data suggest a high prevalence of PG among patients with PD. Dopamine agonist use was strongly associated with PG across all studies. Patients who develop PG present with specific clinical characteristics which are suggestive of underlying susceptibility factors.</p></abstract></profileDesc><revisionDesc><change when="2011-08">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/743E6B37337BCD28D68489871C683C25D343E9A2/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="abstract"><front><journal-meta><journal-id journal-id-type="hwp">jnnp</journal-id><journal-id journal-id-type="nlm-ta">J Neurol Neurosurg Psychiatry</journal-id><journal-id journal-id-type="publisher-id">jnnp</journal-id><journal-title>Journal of Neurology, Neurosurgery & Psychiatry</journal-title><abbrev-journal-title abbrev-type="publisher">J Neurol Neurosurg Psychiatry</abbrev-journal-title><abbrev-journal-title>J Neurol Neurosurg Psychiatry</abbrev-journal-title><issn pub-type="ppub">0022-3050</issn><issn pub-type="epub">1468-330X</issn><publisher><publisher-name>BMJ Publishing Group Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">jnnp-2011-300504.13</article-id><article-id pub-id-type="doi">10.1136/jnnp-2011-300504.13</article-id><article-id pub-id-type="other">jnnp;82/8/e2-m</article-id><article-id pub-id-type="other">jnnp;jnnp-2011-300504.13</article-id><article-id pub-id-type="other">e2.5</article-id><article-id pub-id-type="other">jnnp-2011-300504.13</article-id><article-categories><subj-group subj-group-type="heading"><subject>British Neuropsychiatry Association 24th AGM, 10/11 February 2011, Institute of Child Health, Central London</subject></subj-group><series-title>Members' Forum</series-title></article-categories><title-group><article-title>MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Barns</surname><given-names>M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rickards</surname><given-names>H</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cavanna</surname><given-names>A E</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><month>8</month><year>2011</year></pub-date><volume>82</volume><volume-id pub-id-type="other">82</volume-id><volume-id pub-id-type="other">82</volume-id><issue>8</issue><issue-id pub-id-type="other">jnnp;82/8</issue-id><issue-id pub-id-type="other">8</issue-id><issue-id pub-id-type="other">82/8</issue-id><fpage seq="5">e2</fpage><permissions><copyright-statement>© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</copyright-statement><copyright-year>2011</copyright-year></permissions><self-uri content-type="pdf" xlink:role="full-text" xlink:href="jnnp-82-e2-5.pdf"></self-uri><abstract><sec><title>Aims</title><p>To identify the prevalence of pathological gambling (PG) in patients with Parkinson's disease (PD) from studies using comparable methodology to the best general population estimates. Additionally, to collate case-control based observations regarding the clinical characteristics of this phenomenon.</p></sec><sec><title>Methods</title><p>MEDLINE, EMBASE and PyscInfo databases were searched for prospective prevalence studies which used systematic screening methods and interview based diagnosis using recognised diagnostic criteria for PD. The same search strategy was used to identify case-control studies examining the clinical characteristics of PG.</p></sec><sec><title>Results</title><p>Five prospective studies were included in this review with a total of 1032 patients with PD. 3.2% of all patients fulfilled the diagnostic criteria for PG, compared to 0.43–1% in the general population based on North American surveys. The prevalence in men was 1% higher than in women, although this was not statistically significant. The prevalence of PG among patients on dopamine agonists was 5.7%. Younger age of PD onset, increased novelty seeking behaviours and personal/family history of alcohol misuse were all associated with PG. Psychiatric co-morbidities including other impulse control disorders were commonly reported, although no statistically significant associations have been found.</p></sec><sec><title>Conclusions</title><p>Currently available evidence-based data suggest a high prevalence of PG among patients with PD. Dopamine agonist use was strongly associated with PG across all studies. Patients who develop PG present with specific clinical characteristics which are suggestive of underlying susceptibility factors.</p></sec></abstract></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><partName>Members' Forum</partName><title>MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><partName>Members' Forum</partName><title>MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Barns</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Rickards</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A E</namePart><namePart type="family">Cavanna</namePart><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="abstract" displayLabel="abstract"></genre><originInfo><publisher>BMJ Publishing Group Ltd</publisher><dateIssued encoding="w3cdtf">2011-08</dateIssued><copyrightDate encoding="w3cdtf">2011</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract>Aims To identify the prevalence of pathological gambling (PG) in patients with Parkinson's disease (PD) from studies using comparable methodology to the best general population estimates. Additionally, to collate case-control based observations regarding the clinical characteristics of this phenomenon. Methods MEDLINE, EMBASE and PyscInfo databases were searched for prospective prevalence studies which used systematic screening methods and interview based diagnosis using recognised diagnostic criteria for PD. The same search strategy was used to identify case-control studies examining the clinical characteristics of PG. Results Five prospective studies were included in this review with a total of 1032 patients with PD. 3.2% of all patients fulfilled the diagnostic criteria for PG, compared to 0.43–1% in the general population based on North American surveys. The prevalence in men was 1% higher than in women, although this was not statistically significant. The prevalence of PG among patients on dopamine agonists was 5.7%. Younger age of PD onset, increased novelty seeking behaviours and personal/family history of alcohol misuse were all associated with PG. Psychiatric co-morbidities including other impulse control disorders were commonly reported, although no statistically significant associations have been found. Conclusions Currently available evidence-based data suggest a high prevalence of PG among patients with PD. Dopamine agonist use was strongly associated with PG across all studies. Patients who develop PG present with specific clinical characteristics which are suggestive of underlying susceptibility factors.</abstract><relatedItem type="host"><titleInfo><title>Journal of Neurology, Neurosurgery & Psychiatry</title></titleInfo><titleInfo type="abbreviated"><title>J Neurol Neurosurg Psychiatry</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0022-3050</identifier><identifier type="eISSN">1468-330X</identifier><identifier type="PublisherID">jnnp</identifier><identifier type="PublisherID-hwp">jnnp</identifier><identifier type="PublisherID-nlm-ta">J Neurol Neurosurg Psychiatry</identifier><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>82</number></detail><detail type="issue"><caption>no.</caption><number>8</number></detail><extent unit="pages"><start>e2</start></extent></part></relatedItem><identifier type="istex">743E6B37337BCD28D68489871C683C25D343E9A2</identifier><identifier type="DOI">10.1136/jnnp-2011-300504.13</identifier><identifier type="href">jnnp-82-e2-5.pdf</identifier><identifier type="ArticleID">jnnp-2011-300504.13</identifier><identifier type="local">jnnp;82/8/e2-m</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</accessCondition><recordInfo><recordContentSource>BMJ</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002561 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002561 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:743E6B37337BCD28D68489871C683C25D343E9A2
|texte= MF.02 The prevalence and clinical characteristics of pathological gambling in patients with Parkinson's disease: an evidence based review
}}
| This area was generated with Dilib version V0.6.23. |  |